{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T21:48:24Z","timestamp":1667857704830},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0103-5","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T14:36:53Z","timestamp":1442414213000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Bo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Berggren-S\u00f6derlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nilsson-Ehle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,16]]},"reference":[{"key":"103_CR1","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem. 1999;274:31286\u201390.","journal-title":"J Biol Chem"},{"key":"103_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"C Wolfrum","year":"2005","unstructured":"Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med. 2005;11:418\u201322.","journal-title":"Nat Med"},{"key":"103_CR3","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"C Christoffersen","year":"2011","unstructured":"Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011;108:9613\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","volume":"221","author":"S Elsoe","year":"2012","unstructured":"Elsoe S, Ahnstrom J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, et al. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis. 2012;221:91\u20137.","journal-title":"Atherosclerosis"},{"issue":"2012","key":"103_CR5","first-page":"2100","volume":"1801","author":"YW Hu","year":"2010","unstructured":"Hu YW, Zheng L, Wang Q. Characteristics of apolipoprotein M and its relation to atherosclerosis and diabetes. Biochim Biophys Acta. 2010;1801(2012):2100\u2013015. Epub 2009 Nov 2010.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR6","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2337\/diabetes.52.12.2989","volume":"52","author":"S Richter","year":"2003","unstructured":"Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, Hattersley AT, et al. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes. 2003;52:2989\u201395.","journal-title":"Diabetes"},{"issue":"21","key":"103_CR7","first-page":"21","volume":"23","author":"N Niu","year":"2006","unstructured":"Niu N, Zhu X, Liu Y, Du T, Wang X, Chen D, et al. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab Res Rev. 2006;23(21):21\u20135.","journal-title":"Diabetes Metab Res Rev"},{"key":"103_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7150\/ijms.7696","volume":"11","author":"L Zheng","year":"2014","unstructured":"Zheng L, Luo G, Zhang J, Mu Q, Shi Y, Berggren-Soderlund M, et al. Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases. Int J Med Sci. 2014;11:365\u201372.","journal-title":"Int J Med Sci"},{"key":"103_CR9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbrc.2006.02.022","volume":"342","author":"N Xu","year":"2006","unstructured":"Xu N, Nilsson-Ehle P, Ahren B. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin. Biochem Biophys Res Commun. 2006;342:1174\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"103_CR10","doi-asserted-by":"crossref","first-page":"e105681","DOI":"10.1371\/journal.pone.0105681","volume":"9","author":"L Zheng","year":"2014","unstructured":"Zheng L, Feng Y, Shi Y, Zhang J, Mu Q, Qin L, et al. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats. PLoS One. 2014;9:e105681.","journal-title":"PLoS One"},{"key":"103_CR11","first-page":"256","volume":"2006","author":"N Xu","year":"1761","unstructured":"Xu N, Ahren B, Jiang J, Nilsson-Ehle P. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells. Biochim Biophys Acta. 1761;2006:256\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR12","first-page":"879","volume":"2007","author":"X Zhang","year":"1771","unstructured":"Zhang X, Jiang B, Luo G, Nilsson-Ehle P, Xu N. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro. Biochim Biophys Acta. 1771;2007:879\u201382.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7150\/ijms.8330","volume":"11","author":"G Luo","year":"2014","unstructured":"Luo G, Feng Y, Zhang J, Mu Q, Shi Y, Qin L, et al. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver. Int J Med Sci. 2014;11:1015\u201321.","journal-title":"Int J Med Sci"},{"key":"103_CR14","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","volume":"290","author":"MG Buse","year":"2006","unstructured":"Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 2006;290:E1\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"103_CR15","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1152\/ajpendo.00507.2009","volume":"298","author":"AT Sage","year":"2009","unstructured":"Sage AT, Walter LA, Shi Y, Khan MI, Kaneto H, Capretta A, et al. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab. 2009;298:E499\u2013511.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Pt 3","key":"103_CR16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/bj3240981","volume":"324","author":"A Filippis","year":"1997","unstructured":"Filippis A, Clark S, Proietto J. Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem J. 1997;324(Pt 3):981\u20135.","journal-title":"Biochem J"},{"key":"103_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","volume":"43","author":"JW Anderson","year":"2005","unstructured":"Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43:187\u2013201.","journal-title":"Food Chem Toxicol"},{"key":"103_CR18","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(99)90195-2","volume":"354","author":"LC Rovati","year":"1999","unstructured":"Rovati LC, Annefeld M, Giacovelli G, Schmid K, Setnikar I. Glucosamine in osteoarthritis. Lancet. 1999;354:1640. author reply 1641\u20131642.","journal-title":"Lancet"},{"key":"103_CR19","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","volume":"266","author":"S Marshall","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 1991;266:4706\u201312.","journal-title":"J Biol Chem"},{"key":"103_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-4838(02)00318-7","volume":"1597","author":"S Milewski","year":"2002","unstructured":"Milewski S. Glucosamine-6-phosphate synthase--the multi-facets enzyme. Biochim Biophys Acta. 2002;1597:173\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s001250051599","volume":"44","author":"G Wu","year":"2001","unstructured":"Wu G, Haynes TE, Yan W, Meininger CJ. Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine. Diabetologia. 2001;44:196\u2013202.","journal-title":"Diabetologia"},{"key":"103_CR22","first-page":"2099","volume":"86","author":"MJ Pouwels","year":"2001","unstructured":"Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab. 2001;86:2099\u2013103.","journal-title":"J Clin Endocrinol Metab"},{"key":"103_CR23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diabetes.49.6.926","volume":"49","author":"T Monauni","year":"2000","unstructured":"Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes. 2000;49:926\u201335.","journal-title":"Diabetes"},{"key":"103_CR24","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1152\/ajpendo.2000.278.1.E103","volume":"278","author":"E Heart","year":"2000","unstructured":"Heart E, Choi WS, Sung CK. Glucosamine-induced insulin resistance in 3\u00a0T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2000;278:E103\u201312.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"103_CR25","first-page":"699","volume":"51","author":"I Setnikar","year":"2001","unstructured":"Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung. 2001;51:699\u2013725.","journal-title":"Arzneimittelforschung"},{"key":"103_CR26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.metabol.2003.11.027","volume":"53","author":"MJ Haas","year":"2004","unstructured":"Haas MJ, Wong NC, Mooradian AD. Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells. Metabolism. 2004;53:766\u201371.","journal-title":"Metabolism"},{"key":"103_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000154142.61859.94","volume":"25","author":"W Qiu","year":"2005","unstructured":"Qiu W, Kohen-Avramoglu R, Mhapsekar S, Tsai J, Austin RC, Adeli K. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation. Arterioscler Thromb Vasc Biol. 2005;25:571\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"103_CR28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1194\/jlr.M500363-JLR200","volume":"47","author":"W Qiu","year":"2006","unstructured":"Qiu W, Avramoglu RK, Rutledge AC, Tsai J, Adeli K. Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins. J Lipid Res. 2006;47:1749\u201361.","journal-title":"J Lipid Res"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0103-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T23:00:12Z","timestamp":1653174012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/14\/1\/110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0103-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,16]]},"article-number":"110"}}